Patient Guide: An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 207 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05513001
Status: ACTIVE_NOT_RECRUITING
Condition: Chronic Spontaneous Urticaria
Phase: PHASE3

Where You Can Participate

This study is available at 207 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Birmingham, Alabama
  • • Litchfield Park, Arizona
  • • And 204 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib - Join Clinical Trial NCTNCT05513001

How to Join This Clinical Trial - NCTNCT05513001

Learn how to participate in this PHASE3 trial studying an investigational therapy for Chronic Spontaneous Urticaria. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Spontaneous Urticaria. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Spontaneous Urticaria
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05513001 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 207 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35209 - United States

Status: Contact for availability

Clinical Research Site

Birmingham, Alabama 35244 - United States

Status: Contact for availability

Clinical Research Site

Litchfield Park, Arizona 85340 - United States

Status: Contact for availability

Clinical Research Site

Little Rock, Arkansas 72205 - United States

Status: Contact for availability

Clinical Research Site

North Little Rock, Arkansas 72117 - United States

Status: Contact for availability

Clinical Research Site

Bakersfield, California 93301 - United States

Status: Contact for availability

Clinical Research Site

Lancaster, California 93534 - United States

Status: Contact for availability

Clinical Research Site

Redwood City, California 94063 - United States

Status: Contact for availability

Clinical Research Site

Colorado Springs, Colorado 80907 - United States

Status: Contact for availability

Clinical Research Site

Denver, Colorado 80230 - United States

Status: Contact for availability

And 197 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Chronic Spontaneous Urticaria:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships